Stand Up To Cancer and the St. Baldrick’s Foundation to Fund Innovative Pediatric Cancer Dream Team

Thu, 09/13/2012 - 12:30pm

Following successful SU2C telethon, new details released regarding multi-million dollar childhood cancer research initiative

LOS ANGELES (Sept. 13, 2012) — The St. Baldrick’s Foundation, a charity dedicated to raising awareness and funds for childhood cancer research, and Stand Up To Cancer (SU2C), a groundbreaking initiative created to accelerate collaborative, innovative cancer research, are excited to announce new details about their plan to jointly fund a Pediatric Cancer Dream Team.

Over the next four years, the St. Baldrick’s Foundation, which raises funds through its signature head-shaving events held worldwide and other fundraising activities, and SU2C will commit a total of $14.5 million to the SU2C-St. Baldrick’s Pediatric Cancer Dream Team.

This is the first SU2C Dream Team focused solely on pediatric cancer research since SU2C was launched in 2008. The pairing of the organizations brings together two of the world’s leading cancer research fundraising groups in a unified mission to accelerate the development of new methods to treat pediatric cancers.

Worldwide, a child is diagnosed every three minutes, and in the United States, one in five children diagnosed with cancer will not survive.

On Stand Up To Cancer’s behalf, the American Association for Cancer Research (AACR), its scientific partner, will issue a call for ideas on Sept. 20. Please visit for more information.

A SU2C-St. Baldrick’s Joint Scientific Advisory Committee (JSAC) will conduct a unique, rapid and rigorous evaluation of the applications via a multi-step scientific review process, and make recommendations on the final grant recipients. Since the launch of SU2C, the AACR has played an integral role by providing scientific leadership, expert peer review and grants administration. The AACR is responsible for administering these grants and provides ongoing scientific oversight to ensure that progress is being made.

“The formation of the SU2C-St. Baldrick’s Pediatric Cancer Dream Team has the potential to be a real game changer in the childhood cancer research community,” said Kathleen Ruddy, executive director of the St. Baldrick’s Foundation. “It is through the ongoing efforts of our volunteers who continue to stand up to cancer, and the more than $32 million they raised this year, that we are able to announce this landmark collaboration. We are confident that the innovative approach of the Pediatric Cancer Dream Team, along with other St. Baldrick’s funded research will help quicken the pace in our ultimate goal to someday find cures for all childhood cancers.”

The Dream Team will conduct research focused solely on pediatric cancer. Formation of this team will fulfill the mission of Stand Up To Cancer and the St. Baldrick’s Foundation to fund the most promising research to find cures for childhood cancers and ultimately enable survivors to lead long and healthy lives.

“We were thrilled with the public response to the poignant stories of pediatric cancer patients we featured in our Sept. 7 telethon,” said Sung Poblete, president and chief executive officer of Stand Up To Cancer. “We’re excited to be collaborating with the St. Baldrick’s Foundation to address the urgent need for more pediatric cancer research.”

To date, SU2C has awarded grants to seven Dream Teams, and 26 Innovative Research Grants (IRGs) have been awarded to individual young investigators. These recipients comprise more than 350 scientists from 65 institutions. Of the 26 IRG recipients, seven focus significantly on pediatric cancers, including Ewing sarcoma, rhabdoid tumors and atypical teratoid/rhabdoid tumors (RT).

As the leading non-governmental provider of childhood cancer research grants, the St. Baldrick’s Foundation has awarded more than $101 million in research funding since 2005, and has granted more than $23 million in funding this year alone. The collaboration with SU2C will be the largest financial commitment the foundation has made since its inception.


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.